Health News Highlights: From Gerresheimer's Stock Surge to Novavax's EU Authorization

This health news roundup covers various topics including Gerresheimer's stock jump due to an activist investor, a US list of affordable generic drugs for Medicare, Illumina's new gene sequencers, FTC disqualification requests in the insulin case, Novavax's COVID vaccine approval in the EU, and more.

An upswing for Gerresheimer shares took place on Wednesday, following an announcement that Ricky Chad Sandler had acquired a 5.43% stake in the German medical packaging company. As of 1250 GMT, the shares were up 4%.

The U.S. Centers for Medicare & Medicaid Services unveiled a list of 101 generic drugs priced at no more than $2 for Medicare users. The list includes medications for conditions like high blood pressure and high cholesterol.

In technology advancements, Illumina has launched a new line of compact and affordable gene sequencers to expand research opportunities for studying genetic variations associated with diseases.

(With inputs from agencies.)